Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations

Clinical and Experimental Allergy

Volumn 45, Issue 10, 2015, Pages 1523-1530

  Iwasaki, J ^a   Chai, L Y ^a   Khoo, S K ^a,b   Bizzintino, J ^a,b   Laing, I A ^a,b   Le Souef P N ^b   Thomas, W R ^a   Hales, B J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Asthma; Children; Echovirus; Enteroviruses; IgG1 antibody; Poliovirus; Rhinovirus; VP1

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; PROTEIN VP1; TETANUS TOXOID; CAPSID PROTEIN; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE EXACERBATION; ENTEROVIRUS; ENTEROVIRUS B; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN RHINOVIRUS A; IMMUNOADSORPTION; INTESTINE INFECTION; MALE; NONHUMAN; POLIOMYELITIS VIRUS; PREVALENCE; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; COMPLICATION; ECHOVIRUS INFECTION; IMMUNOLOGY; METABOLISM; PRESCHOOL CHILD;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ASTHMA; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; ECHOVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE;

EID: 84941686821     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12501     Document Type: Article

References (46)

1. Pfefferle PI, Renz H. Microbial exposure and onset of allergic diseases - potential prevention strategies? Allergol Int 2014; 63:3-10.
2. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29:342-6.
3. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129:434-40.
4. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
5. Kusel MM, de Klerk NH, Kebadze T et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-10.
6. Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-72.
7. Thomson JA, Widjaja C, Darmaputra AA et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high-risk cohort: a prospective study of allergy-prone children from birth to six years. Pediatr Allergy Immunol 2010; 21:1076-85.
8. Cullinan P, Harris JM, Newman Taylor AJ et al. Can early infection explain the sibling effect in adult atopy? Eur Respir J 2003; 22:956-61.
9. Matricardi PM, Rosmini F, Riondino S et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000; 320:412-7.
10. Schibler M, Gerlach D, Martinez Y et al. Experimental human rhinovirus and enterovirus interspecies recombination. J Gen Virol 2012; 93:93-101.
11. Korhonen L, Kondrashova A, Tauriainen S et al. Enterovirus infections in early childhood and the risk of atopic disease-a nested case-control study. Clin Exp Allergy 2013; 43:625-32.
12. Iwasaki J, Smith WA, Stone SR, Thomas WR, Hales BJ. Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C. PLoS One 2013; 8:e70552.
13. Iwasaki J, Smith WA, Khoo SK et al. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection. J Allergy Clin Immunol 2014; 134:25-32.
14. Helfand RF, Khan AS, Pallansch MA et al. Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis 1994; 169:1133-7.
15. Mohle-Boetani JC, Matkin C, Pallansch M et al. Viral meningitis in child care center staff and parents: an outbreak of echovirus 30 infections. Public Health Rep 1999; 114:249-56.
16. Vieth UC, Kunzelmann M, Diedrich S et al. An echovirus 30 outbreak with a high meningitis attack rate among children and household members at four day-care centers. Eur J Epidemiol 1999; 15:655-8.
17. McWilliam Leitch EC, Bendig J, Cabrerizo M et al. Transmission networks and population turnover of echovirus 30. J Virol 2009; 83:2109-18.
18. Polio Willyard C. The eradication endgame. Nature 2014; 507:S14-5.
19. Reddel HK, Taylor DR, Bateman ED et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
20. Cox DW, Bizzintino J, Ferrari G et al. Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissions. Am J Respir Crit Care Med 2013; 188:1358-64.
21. Junttila N, Leveque N, Kabue JP et al. New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J Med Virol 2007; 79:393-400.
22. Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 2013; 14:282-93.
23. Laine P, Savolainen C, Blomqvist S, Hovi T. Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol 2005; 86:697-706.
24. Witso E, Cinek O, Aldrin M et al. Predictors of sub-clinical enterovirus infections in infants: a prospective cohort study. Int J Epidemiol 2010; 39:459-68.
25. Sadeharju K, Knip M, Virtanen SM et al. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007; 119:941-6.
26. Juhela S, Hyoty H, Lonnrot M, Roivainen M, Simell O, Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998; 54:226-32.
27. Iwai M, Yoshida H, Obara M et al. Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003. Clin Vaccine Immunol 2010; 17:764-70.
28. Maguire HC, Atkinson P, Sharland M, Bendig J. Enterovirus infections in England and Wales: laboratory surveillance data: 1975 to 1994. Commun Dis Public Health 1999; 2:122-5.
29. Pang IK, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome. Immunol Rev 2012; 245:209-26.
30. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell 2009; 138:30-50.
31. Sommer F, Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013; 11:227-38.
32. Ichinohe T, Pang IK, Kumamoto Y et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA 2011; 108:5354-9.
33. Kinnebrew MA, Pamer EG. Innate immune signaling in defense against intestinal microbes. Immunol Rev 2012; 245:113-31.
34. Luoto R, Ruuskanen O, Waris M, Kalliomaki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy Clin Immunol 2014; 133:405-13.
35. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179-85.
36. Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy 2013; 43:434-42.
37. Abrahamsson TR, Jakobsson T, Bjorksten B, Oldaeus G, Jenmalm MC. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24:556-61.
38. Ma C, Wu X, Nawaz M et al. Molecular characterization of fecal microbiota in patients with viral diarrhea. Curr Microbiol 2011; 63:259-66.
39. Lynch SV. Viruses and microbiome alterations. Ann Am Thorac Soc 2014; 11:S57-60.
40. Wagner KS, White JM, Andrews NJ et al. Immunity to tetanus and diphtheria in the UK in 2009. Vaccine 2012; 30:7111-7.
41. Dannemann A, van Ree R, Kulig M et al. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life. Int Arch Allergy Immunol 1996; 111:262-7.
42. Holt PG, Rudin A, Macaubas C et al. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol 2000; 105:1117-22.
43. Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 2000; 105:692-8.
44. Lee HY, Chen CJ, Huang YC et al. Clinical features of echovirus 6 and 9 infections in children. J Clin Virol 2010; 49:175-9.
45. Jacques J, Moret H, Minette D et al. Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J Clin Microbiol 2008; 46:206-13.
46. Renois F, Leveque N, Deliege PG et al. Enteroviruses as major cause of microbiologically unexplained acute respiratory tract infections in hospitalized pediatric patients. J Infect 2013; 66:494-502.